Title: Differential Regulation of Gene Expression in Lung Cancer Cells by Diacyglycerol-Lactones and a Phorbol Ester Via Selective Activation of Protein Kinase C Isozymes.
Authors: Cooke, Mariana; Casado-Medrano, Victoria; Ann, Jihyae; Lee, Jeewoo; Blumberg, Peter M; Abba, Martin C; Kazanietz, Marcelo G
Published In Sci Rep, (2019 04 15)
Abstract: Despite our extensive knowledge on the biology of protein kinase C (PKC) and its involvement in disease, limited success has been attained in the generation of PKC isozyme-specific modulators acting via the C1 domain, the binding site for the lipid second messenger diacylglycerol (DAG) and the phorbol ester tumor promoters. Synthetic efforts had recently led to the identification of AJH-836, a DAG-lactone with preferential affinity for novel isozymes (nPKCs) relative to classical PKCs (cPKCs). Here, we compared the ability of AJH-836 and a prototypical phorbol ester (phorbol 12-myristate 13-acetate, PMA) to induce changes in gene expression in a lung cancer model. Gene profiling analysis using RNA-Seq revealed that PMA caused major changes in gene expression, whereas AJH-836 only induced a small subset of genes, thus providing a strong indication for a major involvement of cPKCs in their control of gene expression. MMP1, MMP9, and MMP10 were among the genes most prominently induced by PMA, an effect impaired by RNAi silencing of PKCα, but not PKCδ or PKCε. Comprehensive gene signature analysis and bioinformatics efforts, including functional enrichment and transcription factor binding site analyses of dysregulated genes, identified major differences in pathway activation and transcriptional networks between PMA and DAG-lactones. In addition to providing solid evidence for the differential involvement of individual PKC isozymes in the control of gene expression, our studies emphasize the importance of generating targeted C1 domain ligands capable of differentially regulating PKC isozyme-specific function in cellular models.
PubMed ID: 30988374
MeSH Terms: A549 Cells; Diglycerides/pharmacology; Drug Discovery; Enzyme Activation/drug effects*; Gene Expression Regulation, Neoplastic/drug effects*; Humans; Isoenzymes/genetics; Isoenzymes/metabolism; Lactones/pharmacology*; Ligands; Lung Neoplasms/drug therapy; Lung Neoplasms/enzymology; Lung Neoplasms/genetics*; Lung Neoplasms/metabolism; Phorbol Esters/pharmacology*; Protein Kinase C/genetics; Protein Kinase C/metabolism*; Transcriptome/drug effects